Latest Convertible Note Funding News

The Spanish Supreme Court has accepted an appeal that could reshape the permitting process for Highfield Resources’ Muga Project, triggering financing negotiations and legal scrutiny over mining concession procedures.

Native Mineral Resources (ASX:NMR) has raised A$3.5 million through a convertible note with existing investor Lind Global Fund III LP, aiming to reduce debt and support operational cash flow.

Wellnex Life has pushed back the repayment deadline on nearly $3 million owed to former directors by three months, agreeing to additional fees and interest. Former CEO Zack Bozinovski returns as a consultant, suggesting ongoing strategic recalibration.

Core Lithium has greenlit the restart of its Finniss Lithium Project with a fully funded A$290 million package, initiating mining activities and targeting spodumene concentrate production by September 2026.

Highfield Resources (ASX:HFR) has dismissed any undisclosed material information as the cause of its recent share price jump, attributing the volatility to global geopolitical tensions impacting fertiliser raw materials.

Carbonxt Group has secured $750,000 through convertible notes from major shareholder Phelbe Pty Ltd, targeting expansion of its Minnesota pellet manufacturing and increasing its New Carbon Processing stake to 48.1%.

Wellnex Life Limited is exploring acquisition interest and convertible note funding to accelerate Pain Away's expansion and strengthen its financial footing, signaling a pivotal phase in its turnaround journey.

Osteopore Limited has successfully raised the entire $5 million from the first tranche of its $20 million convertible notes issuance, securing funds to support ongoing operations and future growth.

Carbonxt Group Limited reported a strong 72% revenue increase to $3.8 million in Q2 FY26, driven by robust demand and strategic progress at its Kentucky facility, which is poised to triple group sales. The company also increased its stake in New Carbon Processing, advancing its North American growth ambitions.

The Calmer Co. International Limited has reported a second consecutive quarter of revenue exceeding $2 million, driven by strong U.S. growth and record monthly sales in December. The company’s strategic focus on wholesale and B2B extract channels underpins its confidence in reaching breakeven this fiscal year.

Dome Gold Mines has reported a significant construction sand resource at its Sigatoka project in Fiji and is progressing its feasibility study, supported by a proposed $7 million convertible note raise.

Chimeric Therapeutics has raised $8.4 million to fully fund its lead CHM CDH17 CAR-T Phase 1/2 trial through Phase 1, while initiating a strategic reset to sharpen focus and reduce costs.